Anchorage Capital Group, L.L.C. Ginkgo Bioworks Holdings, Inc. Call Options Transaction History
Anchorage Capital Group, L.L.C.
- $316 Million
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DNA
# of Institutions
220Shares Held
718MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.16 Billion0.0% of portfolio
-
Black Rock Inc. New York, NY42MShares$352 Million0.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny31.4MShares$263 Million0.02% of portfolio
-
Legal & General Group PLC London, X027MShares$226 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $10.8B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...